Clinical Trials Logo

Tobacco Use Cessation clinical trials

View clinical trials related to Tobacco Use Cessation.

Filter by:

NCT ID: NCT04001972 Completed - Smoking Cessation Clinical Trials

Interactive Communication Technologies and Nicotine Replacement Therapy Sampling for Smokers

Start date: August 19, 2019
Phase: N/A
Study type: Interventional

Brief advice combined with active referral to smoking cessation (SC) services increases quitting. We aim to strengthen the effect of combined intervention by using interactive communication technologies and nicotine replacement therapy sampling (NRT-S).

NCT ID: NCT03927976 Completed - Clinical trials for Tobacco Use Cessation

Feasibility of a Culturally-Specific Video Text Cessation Intervention With AA Quitline Callers

Start date: April 10, 2019
Phase: N/A
Study type: Interventional

Assess the feasibility and acceptability of delivering an mHealth tobacco intervention among state quitline enrollees.

NCT ID: NCT03873337 Completed - Schizophrenia Clinical Trials

Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)

PTSC-S
Start date: April 22, 2019
Phase: N/A
Study type: Interventional

Due to the pandemic, this study was modified from a randomized clinical trial to test the feasibility, initial efficacy, and mechanisms of action of our PTSC-S intervention to a feasibility and acceptability test of our intervention when delivered via telehealth in a single group, within-subjects design.

NCT ID: NCT03845413 Completed - Clinical trials for Tobacco Use Cessation

Gender-Relevant Tobacco Cessation Among Women in Brazil

Start date: June 20, 2012
Phase: N/A
Study type: Interventional

The overall goal of this renewal is three-fold: (1) to continue to sustain and strengthen the network; (2) to conduct a group randomized controlled trial to assess the efficacy of a theory-based, culturally- and gender-relevant Community Health Worker intervention for Brazilian women "light smokers" that will augment the smoking cessation programs offered through the public health system; and (3) to expand our current Career Development and Research Training Program to the other two major tobacco growing states in order to develop a cadre of well-trained researchers who will continue to develop and implement gender-relevant comprehensive tobacco control strategies at all levels.

NCT ID: NCT03839043 Completed - Clinical trials for Tobacco Use Cessation

Short Messaging Service Program to Help Quit Smoking During Perioperative Period.

SMS2QUIT
Start date: March 18, 2019
Phase: N/A
Study type: Interventional

Smoking can increase the risk of complications around the time of surgery. Researchers are trying to see if a text messaging program can help smokers stay off cigarettes around the time of surgery.

NCT ID: NCT03714191 Completed - Clinical trials for Tobacco Use Cessation

Optimizing the Tobacco Cessation Clinical Decision Support Tool.

Start date: October 3, 2018
Phase:
Study type: Observational

The existing tobacco cessation best practice advisory (BPA) fires for providers (physicians, residents, fellows, midwives, nurse practitioners, physician assistants) during outpatient encounters when a patient is identified as a current tobacco user in the Social History section of their chart. The BPA was designed to help facilitate tobacco cessation interventions; it is part of the The Centers for Medicare & Medicaid Services (CMS) Quality Payment Program (QPP). The purpose of the project is to optimize this BPA utilization and improve patient outcomes by comparing multiple versions of the tobacco cessation BPA.

NCT ID: NCT03671707 Completed - Smoking Cessation Clinical Trials

Brief Advice, Nicotine Replacement Therapy Sampling and Active Referral (BANSAR) for Smoking Fathers

BANSAR
Start date: October 10, 2018
Phase: N/A
Study type: Interventional

This study aims to evaluate the effects of a combined "cocktail", cessation intervention of brief advice, nicotine replacement therapy sampling and active referral (BANSAR) for smoking expectant fathers on smoking cessation outcomes

NCT ID: NCT03645941 Completed - Smoking Cessation Clinical Trials

Connecting Alaska Native People to Quit Smoking

CAN Quit
Start date: December 13, 2019
Phase: N/A
Study type: Interventional

The prevalence of smoking among US adults is highest among American Indians and Alaska Native (AI/AN) persons; however, there are a lack of tobacco cessation interventions developed specific to this disparity group. Social media holds promise as a scalable intervention strategy to promote engagement in treatment and cessation outcomes for Alaska Native (AN) people. Researchers plan to develop and pilot test a culturally relevant, Facebook delivered intervention to promote smoking treatment uptake and cessation among AN smokers. The Facebook content will include a digital storytelling approach adapted from the effective Centers for Disease Control (CDC) Tips from Former Smokers educational mass media campaign. The project builds on the researcher team's longstanding tobacco control research partnership with the AN community and was informed by their understanding of cultural factors that can both impede and encourage cessation in this population. If the pilot intervention is successful, researchers will have a blueprint to conduct a large randomized controlled trial. The researchers long-term objective is to develop interventions for AN tobacco users that will ultimately reduce their risk of tobacco-caused disease and mortality.

NCT ID: NCT03626064 Completed - Clinical trials for Tobacco Use Disorder

The PROMPT Pilot Study

Start date: June 2014
Phase: N/A
Study type: Interventional

The PROMPT Pilot Study is a feasibility mixed methods prospective cohort study following principles of community-based participatory action research. The study recruited 80 people who use drugs and followed them for 6 months while providing access to counselling, nicotine replacement therapy and peer-support in a community setting. A notable reduction in average cigarette use per day (20.5 to 9.3) and illicit substance use (18.8%) was observed at study-end. PROMPT's patient engagement model is an effective harm-reduction strategy for the growing opioid use crisis and can improve the health outcomes of marginalised at-risk populations worldwide.

NCT ID: NCT03567993 Completed - Clinical trials for Tobacco Use Cessation

mHealth Messaging to Motivate Quitline Use Quitting

M2Q2
Start date: November 23, 2018
Phase: N/A
Study type: Interventional

The mHealth Messaging to Motivate Quitline Use and Quitting, or "M2Q2" study, is a collaborative research project for a mobile health intervention designed to motivate smoking cessation and encourage access to counseling. The study is for men and women smokers in Vietnam's Red River Delta region who are 18 years of age or older. The primary hypothesis is that smokers in the M2Q2 intervention will have higher rates of smoking cessation, compared with the comparison group.